Active Biotech raises SEK 43.4 million in substantially oversubscribed rights issue including exercise of over-allotment option
Access to the information and documents on this part of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.